Delivery Order SPE2DR25D1041-SPE2DR26FHP9F
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,441.71 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within...
- The Defense Logistics Agency (DLA) awarded a $24,916.23 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 units) on April 24, 2025, with a ceiling value of $12,746.53. This competitive award, utilizing firm fixed pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,200.07 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's distribution hub...
- The Defense Logistics Agency awarded a delivery order valued at $89,299.27 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $2,869.43 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on October 31, 2025, with completion targeted for November 3, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $18,332.03 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packages) on June 3, 2025, with completion scheduled for June 4, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,520.01 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count supply) on September 16, 2025, with completion expected by September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed-price contract valued at $7,785.96. This non-set-aside award is a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $23,518.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract vehicle running through December 2026. The delivery...
- SPE2DR25D1041Indefinite Delivery Contract
- SPE2DR25D1041-SPE2DR26FHP9FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $36,599.31 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on November 3, 2025, with completion targeted for November 4, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical will be delivered to the contractor's primary location in Conshohocken, Pennsylvania, where AmerisourceBergen operates as a major healthcare solutions provider and critical vendor for federal medical procurement. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which extends through December 2026 and serves as a global pharmaceutical support vehicle. The contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's extensive portfolio of neurological and specialty pharmaceuticals delivered through the DLA medical supply chain to support ongoing federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.6k | 11/3/25 |